Browsing by Author "E Symington"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Item Efficacy safety and quality of life 4 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A in the phase 3 GENEr81 trialA Leavitt; Johnny Mahlangu; P Raheja; E Symington; D Quon; E et alItem Threeyear outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A(WILEY-BLACKWELL) B Madan; M OZELO; P Raheja; E Symington; E et al; Johnny Mahlangu